Hernandez, R., Toomer, K. H., Põder, J., Santos Savio, A., Hsiung, S., & Malek, T. R. (2020). Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8(+) T cells to enhance antitumor immunity. Cancer Immunol Immunother.
Citação norma ChicagoHernandez, Rosmely, Kevin H. Toomer, Janika Põder, Alicia Santos Savio, Sunnie Hsiung, and Thomas R. Malek. "Sustained IL-2R Signaling of Limited Duration By High-dose MIL-2/mCD25 Fusion Protein Amplifies Tumor-reactive CD8(+) T Cells to Enhance Antitumor Immunity." Cancer Immunol Immunother 2020.
Citação norma MLAHernandez, Rosmely, et al. "Sustained IL-2R Signaling of Limited Duration By High-dose MIL-2/mCD25 Fusion Protein Amplifies Tumor-reactive CD8(+) T Cells to Enhance Antitumor Immunity." Cancer Immunol Immunother 2020.